Zimmer Biomet’s flagship robot, Rosa, is expected to make gains in the near future, CEO Ivan Tornos said at the Barclays 27th Annual Global Healthcare Conference. Mr. Tornos said adoption of the robot ...
Zimmer Biomet (NYSE: ZBH) announced today that it received FDA 510(k) clearance for its Persona Revision SoluTion Femur.
Medical Device Network on MSN6d
FDA grants 510(k) clearance to Zimmer’s new revision knee implant componentThe US Food and Drug Administration (FDA) has granted 510(k) clearance to Zimmer Biomet's new revision knee implant component ...
Success in this area could not only drive direct revenue growth from the ROSA system sales but also increase demand for Zimmer Biomet's complementary products and implants used in shoulder procedures.
SINGAPORE, March 30, 2023 /PRNewswire/ -- Zimmer Biomet Holdings ... As a precisely personalized robotic system, ROSA HIP ® enables direct anterior surgeons to evaluate and execute surgical ...
March 10, 2025 /PRNewswire/ -- Zimmer ... System, along with the latest technologies for knee and upper extremity reconstruction and key components from its robotic solutions. In addition, Zimmer ...
The US Food and Drug Administration (FDA) has granted 510(k) clearance to Zimmer Biomet's new revision knee implant ... the implant is part of the Persona Revision Knee System.
For more information about Zimmer Biomet events at AAOS 2025, visit . Important Safety Information for Oxford Cementless Partial Knee: The Oxford® Cementless Partial Knee System is indicated for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback